Pediatr. praxi. 2008;9(2):98-101

Pneumococcal diseases and possibilities of prevention

doc. MUDr. Roman Prymula CSc., Ph.D
Fakulta vojenského zdravotnictví Univerzity obrany, Hradec Králové

Pneumococcal diseases belong among the most frequent respiratory bacterial diseases, afflicting various age cohorts. In children under 2 years of age and vice versa in persons 65 and above are clinical courses the most serious. Streptococcus pneumoniae causes diversiform scale of various diseases in childhood ranging from the most serious invasive like meningitis and septicemias through pneumonias up to life as a rule not threatening but all the more frequent acute otitis and sinusitis. Incidence of pneumococcal diseases varies in different countries. Either the mass immunization strategy or risk group strategy are applied in the EU in current situation. Among the mass strategies schedules 2 plus 1 or 3 plus 1 are put on.

Keywords: pneumococci, invasive pneumococcal diseases, acute otitis media, pneumococcal conjugate vaccine, mass immunization

Published: May 15, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Prymula R, D P. Pneumococcal diseases and possibilities of prevention. Pediatr. praxi. 2008;9(2):98-101.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Balmer P, Borrow R, Findlow J, Warrington R, Frankland S, Waight P, George R, Andrews N, Miller E. Age-Stratified Prevalences of Pneumococcal-Serotype-Specific Immunoglobulin G in England and Their Relationship to the Serotype-Specific Incidence of Invasive Pneumococcal Disease Prior to the Introduction of the Pneumococcal 7-Valent Conjugate Vaccine. Vaccine Immun, Nov. 2007; 14(11): 1442-1450. Go to original source... Go to PubMed...
    2. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH, Lockhart S, Ecrola M. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. New Engl J Med 2001; 344(6): 403-409. Go to original source... Go to PubMed...
    3. Fireman B, Black S, Shinefield H, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 2003; 22(1): 10-16. Go to original source... Go to PubMed...
    4. Handley JO. 2002. Otitis media. N. Engl. J. Med. 347: 1169-1174. Go to original source... Go to PubMed...
    5. Hausdorff WP, Siber G, Paradiso PR. Geographic differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 2001; 357: 950-952. Go to original source... Go to PubMed...
    6. Hausdorff WP. Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Ped 2002; 161 (Suppl. 2): 135-139. Go to original source... Go to PubMed...
    7. Klugman KP, Madhi SA, Huebner RE et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349: 1341-1348. Go to original source... Go to PubMed...
    8. Konradsen HB, Kaltoft MS. Invasive pneumococcal infections in Denmark from 1995 to 1999: Epidemiology, Serotypes, and Resistence. Clinical and Vaccine Imunology, 2002; 9(2): 358-365. Go to original source... Go to PubMed...
    9. Marchetti F, Ronfani L, Nibali SC, Tamburlini G. Delayed prescription may reduce the use of antibiotics for acute otitis media: a prospective observational study in primary care. Personal. Archives of Pediatrics & amp; Adolescent Medicine, 2005, 159(7): 679-684. Go to original source... Go to PubMed...
    10. Motlová J. Distribuce sérotypů a séroskupin Streptococcus pneumoniae u pacientů s invazívními pneumokokovými onemocněními v České republice v letech 1996-2003: podklady pro vakcinační strategii. Epidemiol Mikrobiol Imunol 2005; 1(54): 3-10.
    11. Prymula R. Invazivní pneumokoková onemocnění - incidence ve světě a implikace pro ČR. Pediatr pro Praxi, 2006; 7(6): 334-337.
    12. Prymula R, Peeters P, Chrobok V et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomized double-blind efficacy study. Lancet 2006; 367: 740-748. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.